You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
The Authors' reply
  1. Grazia Grazzini1,
  2. Marco Zappa2,
  3. Leonardo Ventura2,
  4. Tiziana Rubeca3,
  5. Stephen P Halloran4
  1. 1Screening Department, Cancer Prevention and Research Institute (ISPO), Florence, Italy
  2. 2Clinical and Descriptive Epidemiology Department, Cancer Prevention and Research Institute (ISPO), Florence, Italy
  3. 3Bio-molecular and Analytical Cytology Laboratory, Cancer Prevention and Research Institute (ISPO), Florence, Italy
  4. 4Bowel Cancer Screening Southern Programme Hub, Postgraduate Medical School, University of Surrey, Guildford, Surrey GU2 7WG, UK
  1. Correspondence to Grazia Grazzini, Department of Screening, ISPO Cancer Prevention and Research Institute, Viale A. Volta 171, 50131 Firenze, Italy; g.grazzini{at}ispo.toscana.it

https://doi.org/10.1136/gut.2010.230573

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The Authors' reply It is likely that Dr Guittet and colleagues1 are correct in their assertion that a reduction in haemoglobin (Hb) concentration due to in vitro degradation will have a disproportionately large effect on the detection of the small bleeds characteristic of intermediate and high-risk adenomas.2

    As the impetus for worldwide …

    View Full Text

    Footnotes

    • Linked articles 224535.

    • Competing interests None.

    • Provenance and peer review Not commissioned; not externally peer reviewed.

    Linked Articles